about
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancerClass I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivoEffect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitroSuppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanismsHow reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and GynecopathologistsLACTB is a tumour suppressor that modulates lipid metabolism and cell state.High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo.A prognostic gene expression index in ovarian cancer - validation across different independent data sets.An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.Slug and Sox9 cooperatively determine the mammary stem cell state.Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis?Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study.Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays.Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience.Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study.Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans.Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas.Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnoverAmelanotic metastasis of melanoma mimicking ovarian cancer: a case report and review of the literature.The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 StatusARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis.The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancerIdentification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapyDetection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer.De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway.Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis.Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance.CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway.Therapeutic potential of CAMPATH-1H in skeletal tumours.Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics.Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.HMGA2 gene is a promising target for ovarian cancer silencing therapy.Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.
P50
Q21089802-DF6FD346-A1A4-471B-9CDC-2CB51C7C3178Q24312156-A0C249E0-906D-49A1-A082-DD83D8A4B529Q27853018-64140611-A332-4E51-BF91-E1E6D3A9F071Q28247177-7194F784-76E0-4E49-A950-6177A645B0BFQ28729183-DE00031A-86EC-41AD-8CD6-936FF55D0112Q29871523-DF58FBA4-9AAF-490F-9F07-B4E37A8D0EF4Q30884835-2E34C939-E8F5-4C87-BE97-F63E9CBE6705Q33419209-A8BF8605-C2A8-472A-8BFD-CC32872C24FFQ33960748-945F37FB-463C-45B0-8128-01E6DFA8E711Q34030957-896E7176-E010-4A99-9F3C-5491BBC93B79Q34579284-21ADEBEF-56E8-409C-BAF0-8297EC611606Q34756429-E034C4EA-D187-4F68-8F7C-FF5A2036C10BQ35078787-A4F9853D-4920-4AC8-AADA-FD88E69F0D45Q35440724-9114A854-7D8C-4D8F-B201-6906F0ECCBA1Q35810073-1D2036A0-9AE4-424C-9786-5CBBB90082F6Q36235904-0F9B468E-9873-41D7-AB92-9D1DB64FBB28Q36245791-73B2675D-EE86-474B-9409-FEEB09637857Q36254394-20561CAC-BA1A-47E1-A831-4121B7476433Q36386468-73399D8A-076A-4DD4-94ED-3FF5007B8FC6Q36774477-A4D57B77-A028-4A3F-A561-8A556C018C03Q36840303-EBBD70E3-5844-43CA-9F36-5C9A292E15BEQ36942649-45FC5A25-23A4-49C4-BFA6-2F7C0BDC1315Q37126467-76E9FC42-0548-4775-9AD1-918C2A2F0DF5Q37129876-02DF4D9C-74A9-426C-ACD6-4E5DC0BDC54EQ37225222-D8B9BB13-98BF-4253-8F8C-03C972B34C7CQ37280160-75C5FF0E-508A-4525-B378-49321AE8C455Q37451956-B1C42631-0CF4-412F-A8F5-3FA7A71A07F8Q37467199-74121366-0F20-45C6-B4E2-BFAA08551863Q37716446-56AA7ECC-FEE2-4EAF-8C96-9C3D42677DEBQ38338639-5F813757-E5E2-47FE-A6EB-979EE8D51575Q38422475-189EA086-01DB-4731-8941-0EA8D07AB985Q39238692-521EC234-FA67-4882-AEC4-6BFD92D25A77Q39460924-03E9DC73-F1E0-4065-A180-4AFB2BF8DF99Q39580452-FF4F6C38-8CBB-4544-8447-A5FBF4999665Q39618911-0EDE003B-647B-40BE-8D1B-588B5A35D986Q39693444-C5496238-E27D-4DE5-8E91-01B9BF005DC9Q39789349-930E9435-E149-4F30-9CFE-4EDA7C59D81BQ39914477-1FAEB905-1DEE-4D43-9847-2B944917C176Q39986056-D74240FF-75A0-4A77-8A8F-90869DCE221EQ40262886-538736E7-C7C7-476A-A8B9-B76866477D40
P50
description
onderzoeker
@nl
name
Aurelia Noske
@ast
Aurelia Noske
@en
Aurelia Noske
@es
type
label
Aurelia Noske
@ast
Aurelia Noske
@en
Aurelia Noske
@es
prefLabel
Aurelia Noske
@ast
Aurelia Noske
@en
Aurelia Noske
@es